Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1994-2-3
|
pubmed:abstractText |
To evaluate the retention of carbon dioxide in tissue during the reduction of carbonic anhydrase activity following the administration of 5, 10, 20, or 30 mg/kg of acetazolamide in dogs, we measured carbon dioxide pressure (PCO2) in arterial blood, mixed venous blood, alveoli, and tissue. Respiration was maintained at a constant level. In the control (noninjected) group, PCO2 in tissue did not change for 3 hours under controlled respiration. Following the injection of 5 to 30 mg/kg of acetazolamide, PCO2 increased in arterial blood, mixed venous blood, and tissue in a dose-related manner, and decreased in the alveoli. The (a-et)PCO2 widened to 21.9 +/- 1.0 mmHg from 0.6 +/- 1.0 mmHg, and the (t-v)PCO2 to 16.1 +/- 2.0 mmHg from 5.1 +/- 0.6 mmHg, in response to acetazolamide. It is suggested that carbon dioxide is retained in tissue when carbonic anhydrase activity is inhibited by acetazolamide.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0149-2918
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
884-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8269455-Acetazolamide,
pubmed-meshheading:8269455-Animals,
pubmed-meshheading:8269455-Blood Gas Monitoring, Transcutaneous,
pubmed-meshheading:8269455-Carbon Dioxide,
pubmed-meshheading:8269455-Carbonic Anhydrase Inhibitors,
pubmed-meshheading:8269455-Dogs,
pubmed-meshheading:8269455-Eyelids,
pubmed-meshheading:8269455-Lung
|
pubmed:articleTitle |
Retention of carbon dioxide in tissue following carbonic anhydrase inhibition in dogs.
|
pubmed:affiliation |
Department of Emergency Medicine, Saga Medical School, Japan.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|